Zim receives marketing authorization for its innovative product - Sildenafil 50 mg in Spain

12 May 2022 , 05:22 PM

Zim Laboratories announced today that AEPMS – The Spanish Agency for Medicine and Healthcare Products has granted Marketing Authorisation for its innovative product Sildenafil 50 mg ODS in Spain to its wholly owned European Subsidiary – SIA ZIM Laboratories. ZIM Labs is a pioneer in developing Oral Thin Films (OTF) an innovative and novel drug delivery dosage form. The above product is developed using patented Thinoral? technology,which yields instantly wettable, rapidly dissolving, and stable orally dissolving films. The conventional dosage form such as tablet and capsule are difficult to administer, may poses choking hazards and unfriendly to patient convenience. Against the odds of drug intake, oral thin film dissolves instantly after placing on the tongue and results in faster action. Unique features of OTFs and its flexibility offers unparalleled convenience in drug handling and administration. Powered by Capital Market – Live News